We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

179 hedge funds and large institutions have $1.01B invested in Arcus Biosciences in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $7.43M

17% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 60

1.66% more ownership

Funds ownership: 74.27% → 75.93% (+1.7%)

7% less capital invested

Capital invested by funds: $1.09B → $1.01B (-$79.4M)

11% less funds holding

Funds holding: 200 → 179 (-21)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

44% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 43

Holders
179
Holders Change
-21
Holders Change %
-10.5%
% of All Funds
2.85%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
24
Increased
70
Reduced
60
Closed
43
Calls
$10.2M
Puts
$7.43M
Net Calls
+$2.75M
Net Calls Change
+$10.9M

Top Buyers

1
State Street
State Street
Massachusetts
+$37.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$21.5M
3
Bank of America
Bank of America
North Carolina
+$19.3M
4
BlackRock
BlackRock
New York
+$14.3M
5
Walleye Capital
Walleye Capital
New York
+$7.94M

Top Sellers

1
BI
BVF Inc
California
-$47.6M
2
WP
Woodline Partners
California
-$24.8M
3
PHS
PFM Health Sciences
California
-$21.9M
4
FAM
Fred Alger Management
New York
-$11M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$2.96M +$696K +36,413 +29%
Legal & General Group
52
Legal & General Group
United Kingdom
$2.71M -$33.2K -1,735 -1%
TCM
53
Tang Capital Management
California
$2.7M – – –
Axa
54
Axa
France
$2.67M -$6.12K -320 -0.2%
American Century Companies
55
American Century Companies
Missouri
$2.63M +$248 +13 +0%
AG
56
Algert Global
California
$2.12M +$1.96M +102,706 +767%
Two Sigma Advisers
57
Two Sigma Advisers
New York
$2.1M -$1.09M -56,900 -33%
Hudson Bay Capital Management
58
Hudson Bay Capital Management
Connecticut
$2.09M +$1.24M +64,800 +130%
UOC
59
UBS O'Connor
Illinois
$2.09M +$2.19M +114,480 New
PHP
60
Parkman Healthcare Partners
Connecticut
$1.88M +$297K +15,527 +18%
New York State Teachers Retirement System (NYSTRS)
61
New York State Teachers Retirement System (NYSTRS)
New York
$1.82M +$308K +16,100 +19%
UBS Group
62
UBS Group
Switzerland
$1.8M +$744K +38,909 +65%
Victory Capital Management
63
Victory Capital Management
Texas
$1.72M +$543K +28,403 +43%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.71M -$206K -10,800 -10%
Public Sector Pension Investment Board (PSP Investments)
65
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.67M -$60.3K -3,155 -3%
Squarepoint
66
Squarepoint
New York
$1.6M +$1.03M +53,961 +160%
PA
67
Parallel Advisors
California
$1.56M +$4.3K +225 +0.3%
Wells Fargo
68
Wells Fargo
California
$1.49M +$1.5M +78,312 +2,521%
Norges Bank
69
Norges Bank
Norway
$1.46M +$917K +47,998 +151%
FAM
70
Fred Alger Management
New York
$1.42M -$11M -573,601 -88%
PA
71
Profund Advisors
Maryland
$1.42M +$1.49M +77,772 New
GTC
72
Ghost Tree Capital
New York
$1.37M +$1.43M +75,000 New
Allianz Asset Management
73
Allianz Asset Management
Germany
$1.29M +$1.35M +70,600 New
CSS
74
Cubist Systematic Strategies
Connecticut
$1.24M -$781K -40,874 -38%
Prudential Financial
75
Prudential Financial
New Jersey
$1.17M -$35.6K -1,865 -3%
1 2
3
4 5

RCUS Hedge Fund Activity: Q1 2023 in Review

179 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2023, worth a combined $1.01B — down 7.3% from $1.09B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of RCUS and 24 opened new positions — a net loss of 19 holders — while 60 trimmed existing stakes and 70 added.

The largest buyer was State Street, adding an estimated $37.3M. The largest seller was BVF Inc, exiting entirely with an estimated $47.6M sold.

  • 179 institutional investors held Arcus Biosciences (RCUS) as of Q1 2023, down from 200 in Q4 2022.
  • Funds reported $1.01B of Arcus Biosciences stock for Q1 2023, down 7.3% quarter-over-quarter.
  • 24 funds opened new Arcus Biosciences positions in Q1 2023 and 43 closed out, a net change of -19 holders.
  • The largest Arcus Biosciences buyer in Q1 2023 was State Street, an estimated $37.3M added.
  • The largest Arcus Biosciences seller in Q1 2023 was BVF Inc, an estimated $47.6M sold.

Based on aggregated 13F filings for Q1 2023.